[go: up one dir, main page]

GB0611463D0 - Organic compounds - Google Patents

Organic compounds

Info

Publication number
GB0611463D0
GB0611463D0 GB0611463A GB0611463A GB0611463D0 GB 0611463 D0 GB0611463 D0 GB 0611463D0 GB 0611463 A GB0611463 A GB 0611463A GB 0611463 A GB0611463 A GB 0611463A GB 0611463 D0 GB0611463 D0 GB 0611463D0
Authority
GB
United Kingdom
Prior art keywords
organic compounds
compounds
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0611463A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Priority to GB0611463A priority Critical patent/GB0611463D0/en
Publication of GB0611463D0 publication Critical patent/GB0611463D0/en
Priority to EP07730060A priority patent/EP2032599A2/en
Priority to PCT/EP2007/055726 priority patent/WO2007141346A2/en
Ceased legal-status Critical Current

Links

GB0611463A 2006-06-09 2006-06-09 Organic compounds Ceased GB0611463D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GB0611463A GB0611463D0 (en) 2006-06-09 2006-06-09 Organic compounds
EP07730060A EP2032599A2 (en) 2006-06-09 2007-06-11 Genes regulating intracellular cholesterol trafficking as targets for treatment of cholesterol-related diseases
PCT/EP2007/055726 WO2007141346A2 (en) 2006-06-09 2007-06-11 Genes regulating intracellular cholesterol trafficking as targets for treatment of cholesterol-related diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0611463A GB0611463D0 (en) 2006-06-09 2006-06-09 Organic compounds

Publications (1)

Publication Number Publication Date
GB0611463D0 true GB0611463D0 (en) 2006-07-19

Family

ID=36745624

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0611463A Ceased GB0611463D0 (en) 2006-06-09 2006-06-09 Organic compounds

Country Status (3)

Country Link
EP (1) EP2032599A2 (en)
GB (1) GB0611463D0 (en)
WO (1) WO2007141346A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009140972A2 (en) 2008-05-22 2009-11-26 H. Lundbeck A/S Modulation of the vps10p-domain receptors for the treatment of cardiovascular disease
ES2595579T3 (en) 2009-06-10 2017-01-02 Aarhus Universitet SorCS1 type agent for use in the treatment of insulin resistance and related diseases
US9320711B2 (en) 2010-06-25 2016-04-26 Shire Human Genetic Therapies, Inc. Methods and compositions for CNS delivery of heparan N-sulfatase
JP6063380B2 (en) * 2010-06-25 2017-01-18 シャイアー ヒューマン ジェネティック セラピーズ インコーポレイテッド Treatment of Sanfilipo syndrome type B
ES2754234T3 (en) 2010-06-25 2020-04-16 Shire Human Genetic Therapies Methods and compositions for CNS administration of iduronate-2-sulfatase
NZ605865A (en) 2010-06-25 2015-07-31 Shire Human Genetic Therapies Cns delivery of therapeutic agents
ES2896060T3 (en) 2010-06-25 2022-02-23 Shire Human Genetic Therapies Methods and compositions for CNS administration of arylsulfatase A
EP2585104B1 (en) 2010-06-25 2019-08-21 Shire Human Genetic Therapies, Inc. Methods and compositions for cns delivery of arylsulfatase a
CN106279433A (en) * 2011-03-04 2017-01-04 夏尔人类遗传治疗公司 Peptide junctional complex and using method thereof for polypeptide constituent
US8580922B2 (en) 2011-03-04 2013-11-12 Shire Human Genetic Therapies, Inc. Peptide linkers for polypeptide compositions and methods for using same
EP2793922B1 (en) 2011-12-23 2019-10-30 Shire Human Genetic Therapies, Inc. Stable formulations for cns delivery of arylsulfatase a

Also Published As

Publication number Publication date
WO2007141346A3 (en) 2008-04-03
EP2032599A2 (en) 2009-03-11
WO2007141346A2 (en) 2007-12-13
WO2007141346A9 (en) 2009-10-01

Similar Documents

Publication Publication Date Title
GB0610242D0 (en) Organic compounds
GB0606774D0 (en) Organic compounds
GB0603684D0 (en) Organic compounds
ZA200900263B (en) Organic compounds
GB0605691D0 (en) Organic Compounds
GB0606429D0 (en) Organic compounds
GB0605689D0 (en) Organic compounds
GB0605120D0 (en) Organic Compounds
GB0605688D0 (en) Organic compounds
GB0604937D0 (en) Organic compounds
GB0611463D0 (en) Organic compounds
GB0601406D0 (en) Organic Compounds
GB0603782D0 (en) Organic compounds
GB0602123D0 (en) Organic compounds
GB0601951D0 (en) Organic compounds
GB0624814D0 (en) Organic compounds
GB0606804D0 (en) Organic Compounds
GB0606562D0 (en) Organic compounds
GB0603880D0 (en) Organic compounds
GB0611696D0 (en) Organic compounds
GB0606202D0 (en) Organic compounds
GB0601405D0 (en) Organic Compounds
GB0600618D0 (en) Organic compounds
GB0600238D0 (en) Organic compounds
GB0603881D0 (en) Organic compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)